Hye-Jung Kim

Hye-Jung Kim

Company: Dana-Farber Cancer Institute

Job title: Lead Investigator

Seminars:

Helios, Treg Stability & Contribution to Anti-Tumor Immunity 12:00 pm

Discussing Helios as a common transcription factor for CD8 and CD4 Treg Targeting Helios to achieve selective induction of Treg instability under inflammatory conditionsRead more

day: Pre-Conference Focus Day

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.